Forvis Mazars Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Sell
7,895
-188
-2% -$50.9K 0.04% 148
2025
Q4
$2.03M Sell
8,083
-103
-1% -$27.4K 0.04% 157
2025
Q3
$2.35M Sell
8,186
-343
-4% -$91.9K 0.05% 141
2025
Q2
$2.24M Sell
8,529
-209
-2% -$50.9K 0.05% 149
2025
Q1
$2.03M Sell
8,738
-30
-0.3% -$7.28K 0.05% 149
2024
Q4
$2.01M Sell
8,768
-180
-2% -$41.3K 0.05% 160
2024
Q3
$2M Sell
8,948
-2,057
-19% -$452K 0.05% 162
2024
Q2
$2.24M Buy
11,005
+2,299
+26% +$468K 0.06% 149
2024
Q1
$1.9M Sell
8,706
-1,120
-11% -$247K 0.05% 163
2023
Q4
$2.23M Sell
9,826
-932
-9% -$196K 0.06% 142
2023
Q3
$2.16M Sell
10,758
-1,662
-13% -$351K 0.07% 146
2023
Q2
$2.57M Buy
12,420
+285
+2% +$55.3K 0.08% 147
2023
Q1
$2.39M Sell
12,135
-104
-0.8% -$21.4K 0.08% 134
2022
Q4
$2.48M Sell
12,239
-536
-4% -$105K 0.09% 128
2022
Q3
$2.25M Sell
12,775
-368
-3% -$75.3K 0.09% 130
2022
Q2
$2.65M Sell
13,143
-692
-5% -$148K 0.11% 104
2022
Q1
$3.13M Buy
13,835
+721
+5% +$170K 0.13% 83
2021
Q4
$3.54M Sell
13,114
-230
-2% -$56.9K 0.15% 74
2021
Q3
$3.23M Sell
13,344
-441
-3% -$111K 0.15% 71
2021
Q2
$3.27M Sell
13,785
-1,289
-9% -$294K 0.15% 70
2021
Q1
$3.3M Sell
15,074
-919
-6% -$184K 0.16% 67
2020
Q4
$2.8M Buy
15,993
+869
+6% +$150K 0.14% 80
2020
Q3
$2.45M Sell
15,124
-426
-3% -$67.5K 0.14% 75
2020
Q2
$2.22M Sell
15,550
-1,549
-9% -$214K 0.14% 75
2020
Q1
$1.86M Sell
17,099
-637
-4% -$91.8K 0.15% 71
2019
Q4
$2.58M Sell
17,736
-546
-3% -$78.8K 0.19% 69
2019
Q3
$2.64M Sell
18,282
-92
-0.5% -$13.4K 0.21% 65
2019
Q2
$2.73M Sell
18,374
-184
-1% -$25.7K 0.22% 62
2019
Q1
$2.44M Buy
18,558
+2,099
+13% +$259K 0.2% 69
2018
Q4
$1.79M Sell
16,459
-739
-4% -$99K 0.18% 65
2018
Q3
$2.57M Sell
17,198
-332
-2% -$50.5K 0.22% 57
2018
Q2
$2.7M Buy
17,530
+765
+5% +$115K 0.26% 54
2018
Q1
$2.33M Sell
16,765
-6
-0% -$881 0.23% 59
2017
Q4
$2.3M Buy
16,771
+472
+3% +$62.4K 0.23% 63
2017
Q3
$2.11M Sell
16,299
-208
-1% -$27.7K 0.23% 63
2017
Q2
$2.19M Sell
16,507
-47
-0.3% -$5.75K 0.25% 61
2017
Q1
$2.04M Buy
16,554
+719
+5% +$85.1K 0.25% 56
2016
Q4
$1.75M Buy
15,835
+535
+3% +$59.4K 0.23% 60
2016
Q3
$1.81M Buy
15,300
+49
+0.3% +$5.77K 0.25% 50
2016
Q2
$1.71M Sell
15,251
-244
-2% -$26.3K 0.25% 52
2016
Q1
$1.56M Buy
15,495
+921
+6% +$88.3K 0.25% 52
2015
Q4
$1.55M Sell
14,574
-322
-2% -$33.2K 0.23% 50
2015
Q3
$1.39M Sell
14,896
-1,811
-11% -$187K 0.24% 54
2015
Q2
$1.74M Sell
16,707
-46
-0.3% -$4.79K 0.26% 51
2015
Q1
$1.81M Sell
16,753
-404
-2% -$41.5K 0.26% 53
2014
Q4
$1.59M Sell
17,157
-371
-2% -$32.8K 0.26% 57
2014
Q3
$1.53M Sell
17,528
-238
-1% -$21.5K 0.26% 55
2014
Q2
$1.56M Sell
17,766
-371
-2% -$32.1K 0.27% 53
2014
Q1
$1.53M Sell
18,137
-275
-1% -$21.9K 0.27% 58
2013
Q4
$1.45M Buy
18,412
+1,117
+6% +$95.3K 0.27% 57
2013
Q3
$1.47M Sell
17,295
-809
-4% -$68.1K 0.3% 57
2013
Q2
$1.56M Buy
+18,104
New +$1.5M 1.23% 33

Other funds holding LH

Forvis Mazars Wealth Advisors's LH Position: Q1 2026 in Review

Forvis Mazars Wealth Advisors reduced its Labcorp (LH) stake by 2.3% in Q1 2026, selling an estimated $50.9K and leaving 7,895 shares worth $2.11M. The position accounts for 0.04% of the portfolio, ranked #148.

Forvis Mazars Wealth Advisors first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.54M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Forvis Mazars Wealth Advisors held 7,895 shares of Labcorp worth $2.11M as of Q1 2026.
  • Forvis Mazars Wealth Advisors sold 188 Labcorp shares in Q1 2026, an estimated $50.9K.
  • Labcorp made up 0.04% of Forvis Mazars Wealth Advisors's portfolio in Q1 2026, its #148 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Forvis Mazars Wealth Advisors's Labcorp position peaked at $3.54M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.